Used in research to modulate fatty acid elongation, particularly in studies related to metabolic diseases such as obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). It targets the ELOVL6 enzyme, which is involved in the elongation of saturated and monounsaturated fatty acids, making it a tool compound for investigating lipid metabolism and its impact on cellular signaling and disease progression. Its application is primarily in preclinical studies to understand how altering fatty acid composition affects metabolic health and disease mechanisms.